Control Ab, Anti-CD20 from Promega

The Control Antibody, Anti-CD20, is specifically designed for use in the ADCC Reporter Bioassay, providing a biologically relevant and specific measure of antibody-dependent cellular cytotoxicity (ADCC) without the complexities and variability associated with primary cell-based assays.

While the Control Antibody, Anti-CD20, is optimized for the ADCC Reporter Bioassay, the specific cell types it can be used with are not detailed in the provided information. Therefore, it is advisable to consult additional resources or literature for specific applications in different cell types.

The Control Antibody, Anti-CD20, is supplied in a quantity of 5 micrograms. This amount may be suitable for preliminary experiments or smaller-scale assays, but researchers should consider their specific experimental needs and the number of replicates required when planning their studies.

The Control Antibody, Anti-CD20, offers the advantage of a simplified workflow and reduced variability in results, making it a valuable tool for researchers looking to measure ADCC in a more consistent and reliable manner compared to traditional primary cell-based assays.